Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients-authors' response

被引：0
|
作者：
Wu, Tzong-Yow [1 ]
Chen, Pao-Yu [1 ,2 ]
Wang, Jann-Tay [1 ,3 ]
Liu, Wang-Da [4 ]
Chen, Yee-Chun [1 ,3 ,5 ]
Chang, Shan-Chwen [1 ,5 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[2] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
[3] Natl Inst Infect Dis & Vaccinol, Natl Hlth Res Inst, Zhunan, Taiwan
[4] Natl Taiwan Univ, Dept Internal Med, Canc Ctr, Taipei, Taiwan
[5] Natl Taiwan Univ, Sch Med, Coll Med, Taipei, Taiwan
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2024年 / 79卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：3360 / 3361
页数：2
相关论文
共 50 条
  • [31] Breakthrough SARS-CoV-2 infections among recipients of tixagevimab-cilgavimab prophylaxis: A citywide real-world effectiveness study
    Lendacki, Frances R.
    Li, Linda
    Forrest, Graeme N.
    Jordan, Leirah
    Zelinski, Christy
    Black, Stephanie R.
    Ison, Michael G.
    Seo, Jennifer Y.
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (01)
  • [32] Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Stuver, Robert
    Shah, Gunjan L.
    Korde, Neha S.
    Roeker, Lindsey E.
    Mato, Anthony R.
    Batlevi, Connie L.
    Chung, David J.
    Doddi, Sital
    Falchi, Lorenzo
    Gyurkocza, Boglarka
    Hamilton, Audrey
    Lin, Ya-Hui
    Jakubowski, Ann A.
    Joffe, Erel
    Landau, Heather L.
    Lin, Richard J.
    Mailankody, Sham
    Palomba, M. Lia
    Park, Jae H.
    Perales, Miguel-Angel
    Ponce, Doris M.
    V. Ramanathan, Lakshmi
    Salles, Gilles A.
    Scordo, Michael
    Seo, Susan K.
    Shah, Urvi A.
    Stein, Eytan M.
    Straus, David
    Usmani, Saad Z.
    Young, James W.
    Zelenetz, Andrew D.
    Noy, Ariela
    Vardhana, Santosha A.
    CANCER CELL, 2022, 40 (06) : 590 - 591
  • [33] THE USE OF SINGLE THERAPY WITH TOCILIZUMAB VERSUS COMBINATION THERAPY WITH REMDESIVIR IN SARS-COV-2 PATIENTS IN EL PASO TEXAS
    Almaghlouth, Nouf K.
    Shah, Sidra
    Haq, Syed
    Anyiam, Felix E.
    Attia, Mohamed J.
    Guevara, Roberto
    Antony, Suresh
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S27 - S27
  • [34] Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients
    Sepulcri, Chiara
    Bartalucci, Claudia
    Mikulska, Malgorzata
    CURRENT OPINION IN INFECTIOUS DISEASES, 2024, 37 (06) : 506 - 517
  • [35] Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated With AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants
    Tuffy, Kevin M.
    Ahani, Bahar
    Aksyuk, Anastasia A.
    Avila, Miles
    Brady, Tyler
    Kijak, Gustavo H.
    Koh, Gavin
    Levin, Myron J.
    Roe, Tiffany L.
    Schuko, Nicolette
    Thissen, Jesse
    Ustianowski, Andrew
    Zhang, Tianhui
    Kelly, Elizabeth J.
    Streicher, Katie
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (08): : 1055 - 1059
  • [36] Tixagevimab and Cilgavimab (Evusheld) boosts antibody levels to SARS-CoV-2 in patients with multiple sclerosis on b-cell depleters
    Conte, William L.
    Golzarri-Arroyo, Lilian
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 63
  • [37] Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough infections after tixagevimab-cilgavimab during community transmission of monoclonal antibody resistant variants
    Kamboj, Mini
    Laracy, Justin C.
    Usiak, Shauna
    Babady, N. Esther
    Yan, Judy
    Seo, Susan K.
    JOURNAL OF INFECTION, 2023, 87 (03) : 282 - 285
  • [38] Tixagevimab and cilgavimab (Evusheld) boosts antibody levels to SARS-CoV-2 in patients with multiple sclerosis on b-cell depleters
    Conte, W.
    Golzarri-Arroyo, L.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 868 - 869
  • [39] The Use of Single Therapy With Tocilizumab Versus Combination Therapy With Remdesivir and Tocilizumab in SARS-CoV-2 Patients in El Paso, Texas
    Almaghlouth, Nouf K.
    Anyiam, Felix E.
    Shah, Sidra
    Haq, Syed
    Attia, Mohamed J.
    Guevara, Roberto
    Antony, Suresh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [40] Humoral Response to SARS-CoV-2 in Hemodialysis Patients
    Steers, Nicholas J.
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (07): : 1761 - 1763
12345